Curving Tuberculosis: Current Trends and Future Needs

Tuberculosis (TB) presents new challenges as a global public health problem, especially at a time of increasing threats to some particular patients due to Human Immunodeficiency Virus (HIV) infection and multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of Mycobacterium tubercul...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: B. Rojano, J. A. Caminero, M. Hayek
Formato: article
Lenguaje:EN
Publicado: Ubiquity Press 2019
Materias:
Acceso en línea:https://doaj.org/article/6d1c7180e09f42118b9cabac67df0561
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6d1c7180e09f42118b9cabac67df0561
record_format dspace
spelling oai:doaj.org-article:6d1c7180e09f42118b9cabac67df05612021-12-02T01:06:56ZCurving Tuberculosis: Current Trends and Future Needs2214-999610.5334/aogh.2415https://doaj.org/article/6d1c7180e09f42118b9cabac67df05612019-01-01T00:00:00Zhttps://annalsofglobalhealth.org/articles/2415https://doaj.org/toc/2214-9996Tuberculosis (TB) presents new challenges as a global public health problem, especially at a time of increasing threats to some particular patients due to Human Immunodeficiency Virus (HIV) infection and multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis. The World Health Assembly strives to reduce TB deaths by 95% and to decrease TB incidence by 95% by 2035. However, new approaches are necessary in order to attain these objectives. Such approaches include active ascertainment of cases in high risk populations, increasing the availability of accurate point-of-care testing, rapid detection of drug resistance, novel vaccines, and new prophylaxis and treatment regimens (particularly for MDR and XDR TB). The ultimate objective of those programs is to develop highly effective drug regimens that can achieve high cure rates regardless of strains’ resistance patterns.B. RojanoJ. A. CamineroM. HayekUbiquity PressarticleInfectious and parasitic diseasesRC109-216Public aspects of medicineRA1-1270ENAnnals of Global Health, Vol 85, Iss 1 (2019)
institution DOAJ
collection DOAJ
language EN
topic Infectious and parasitic diseases
RC109-216
Public aspects of medicine
RA1-1270
spellingShingle Infectious and parasitic diseases
RC109-216
Public aspects of medicine
RA1-1270
B. Rojano
J. A. Caminero
M. Hayek
Curving Tuberculosis: Current Trends and Future Needs
description Tuberculosis (TB) presents new challenges as a global public health problem, especially at a time of increasing threats to some particular patients due to Human Immunodeficiency Virus (HIV) infection and multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis. The World Health Assembly strives to reduce TB deaths by 95% and to decrease TB incidence by 95% by 2035. However, new approaches are necessary in order to attain these objectives. Such approaches include active ascertainment of cases in high risk populations, increasing the availability of accurate point-of-care testing, rapid detection of drug resistance, novel vaccines, and new prophylaxis and treatment regimens (particularly for MDR and XDR TB). The ultimate objective of those programs is to develop highly effective drug regimens that can achieve high cure rates regardless of strains’ resistance patterns.
format article
author B. Rojano
J. A. Caminero
M. Hayek
author_facet B. Rojano
J. A. Caminero
M. Hayek
author_sort B. Rojano
title Curving Tuberculosis: Current Trends and Future Needs
title_short Curving Tuberculosis: Current Trends and Future Needs
title_full Curving Tuberculosis: Current Trends and Future Needs
title_fullStr Curving Tuberculosis: Current Trends and Future Needs
title_full_unstemmed Curving Tuberculosis: Current Trends and Future Needs
title_sort curving tuberculosis: current trends and future needs
publisher Ubiquity Press
publishDate 2019
url https://doaj.org/article/6d1c7180e09f42118b9cabac67df0561
work_keys_str_mv AT brojano curvingtuberculosiscurrenttrendsandfutureneeds
AT jacaminero curvingtuberculosiscurrenttrendsandfutureneeds
AT mhayek curvingtuberculosiscurrenttrendsandfutureneeds
_version_ 1718403321389121536